TBCTE-101

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTBCTE-101
Drug Alias NameTBCTE-101
ClassificationOther
Mechanisms of ActionInflammation mediator inhibitorsCell replacementsNeurogenesis stimulants
TargetsNot applicable
Therapy Area/IndicationsBrain Damage, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFibroGenesis
China Registration ClassN/A

Develop Information

Active CompaniesFibroGenesis
Inactive CompaniesN/A
Active IndicationsBrain Damage, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A